Cardiorenal Biomarkers and their Implications in Prognosis and Treatment Response of Transthyretin Cardiac Amyloidosis

Artrish Jefferson, Priyanka Narvekar, Bethany Roehm, Robert Toto, Lori Roth, Justin L. Grodin

Open source

DOI
10.1007/s11897-026-00754-z
Published
2026-03-26
Container
Current Heart Failure Reports
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11897-026-00754-z,
  title = {Cardiorenal Biomarkers and their Implications in Prognosis and Treatment Response of Transthyretin Cardiac Amyloidosis},
  author = {Artrish Jefferson and Priyanka Narvekar and Bethany Roehm and Robert Toto and Lori Roth and Justin L. Grodin},
  year = {2026},
  journal = {Current Heart Failure Reports},
  doi = {10.1007/s11897-026-00754-z},
  url = {https://doi.org/10.1007/s11897-026-00754-z}
}

RIS

TY  - JOUR
TI  - Cardiorenal Biomarkers and their Implications in Prognosis and Treatment Response of Transthyretin Cardiac Amyloidosis
AU  - Artrish Jefferson
AU  - Priyanka Narvekar
AU  - Bethany Roehm
AU  - Robert Toto
AU  - Lori Roth
AU  - Justin L. Grodin
PY  - 2026
JO  - Current Heart Failure Reports
DO  - 10.1007/s11897-026-00754-z
UR  - https://doi.org/10.1007/s11897-026-00754-z
ER  - 

APA

Jefferson, A., Narvekar, P., Roehm, B., Toto, R., Roth, L., & Grodin, J. L. (2026). Cardiorenal Biomarkers and their Implications in Prognosis and Treatment Response of Transthyretin Cardiac Amyloidosis. Current Heart Failure Reports. https://doi.org/10.1007/s11897-026-00754-z

Source records